One potentially treatable mechanism of vascular occlusion would be vasculitis. Other than in the setting of overlapping sicca syndrome,'2 vasculitis of any sort or degree is considered uncommon in scleroderma. This issue contains two reports from Herrick et al suggesting the contrary. The first describes an unfortunate individual with long standing diffuse scleroderma who presented with clinical and histopathological evidence of diffuse vasculitis in overlap with active myositis. Clinical and laboratory studies were convincing enough to warrant aggressive glucocorticoid and cyclophosphamide therapy.'3 Such an overt presentation of vasculitis in scleroderma is so rare, however, that it excludes an important cause and effect relationship.
The second report retrospectively surveys patients at their centre with digital ischaemia sufficiently severe to warrant surgical amputation. 4 Vasculitis of diverse vascular location, histology and severity was present in five of nine subjects. Low levels of anticardiolipin antibody were present in four. Other than cigarette smoking in seven, these individuals are notable for their lack of commonality and their general lack of other clinical and laboratory features that suggested vasculitis.
The question inevitably arises as to the advisability of glucocorticoid and/or immunosuppressant therapy for major digital ischaemia presumably due to vasculitis. Glucocorticoid therapy at any level is associated with increased mortality in systemic sclerosis and with increased specific morbidity. The development of non-hypertensive renal failure in diffuse scleroderma receiving moderate glucocorticoid is but one example. 5 In our own experience, individuals with isolated pulmonary hypertension are twice as likely as matched control subjects to have received glucocorticoids in the past. Data from the American studies of iloprost link glucocorticoid therapy to the development of digital tip ulcerations as well.9 Impairment of endothelial prostacyclin production by glucocorticoid is a likely mechanism although other prothrombotic effects need be considered. '5 16 There are multiple plausible opportunities for intervention (table) in the patient with an ischaemically comprised digit. First and foremost is smoking cessation. 
